Variants for Coronary Disease | GenomeWeb

Variants for Coronary Disease

Premium

The Wellcome Trust Centre for Human Genetics' Martin Farrall and his colleagues at the Procardis consortium linked two variants in the lipoapoprotein(a) gene to an increased risk of coronary disease and an increased level of Lp(a) in the blood. Their large-scale study was recently published in the New England Journal of Medicine. GT's Ciara Curtin caught up with Farrall to discuss his work.

Genome Technology: Why did you focus on variants associated with Lp(a) lipoprotein levels?

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.